Beijing Wantai Biological Pharmacy Enterprise (603392.SH): TB-IGRA test kit is included in the United Nations Development Programme procurement list.

Beijing Wantai Biological Pharmacy Enterprise (603392.SH) announced that its independently developed tuberculosis infection T-cell test kit (TB-IGRA test kit), using an enzyme-linked immunosorbent assay, has been included in the procurement list managed by the StopTB Partnership under the United Nations Office for Project Services (UNOPS). The announcement stated that as a key procurement agency within the United Nations system, the inclusion of the company's TB-IGRA test kit in the UNOPS procurement list signifies international recognition and allows the company to participate in centralized procurement projects of the United Nations and other global multilateral organizations, covering more developing countries and regions. This will positively impact the companys international market expansion and further enhance the international competitiveness of its products. Tuberculosis is a global public health issue, and organizations such as UNOPS pay special attention to tuberculosis screening and prevention products in medical supplies procurement. The companys TB-IGRA test kit entering into such procurement chains through UNOPS will help meet the testing needs for tuberculosis in low- and middle-income countries worldwide.